Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 25
Filter
1.
J Exp Med ; 213(5): 657-65, 2016 05 02.
Article in English | MEDLINE | ID: mdl-27045008

ABSTRACT

NLRs (nucleotide-binding domain [NBD] leucine-rich repeat [LRR]-containing proteins) exhibit diverse functions in innate and adaptive immunity. NAIPs (NLR family, apoptosis inhibitory proteins) are NLRs that appear to function as cytosolic immunoreceptors for specific bacterial proteins, including flagellin and the inner rod and needle proteins of bacterial type III secretion systems (T3SSs). Despite strong biochemical evidence implicating NAIPs in specific detection of bacterial ligands, genetic evidence has been lacking. Here we report the use of CRISPR/Cas9 to generate Naip1(-/-) and Naip2(-/-) mice, as well as Naip1-6(Δ/Δ) mice lacking all functional Naip genes. By challenging Naip1(-/-) or Naip2(-/-) mice with specific bacterial ligands in vivo, we demonstrate that Naip1 is uniquely required to detect T3SS needle protein and Naip2 is uniquely required to detect T3SS inner rod protein, but neither Naip1 nor Naip2 is required for detection of flagellin. Previously generated Naip5(-/-) mice retain some residual responsiveness to flagellin in vivo, whereas Naip1-6(Δ/Δ) mice fail to respond to cytosolic flagellin, consistent with previous biochemical data implicating NAIP6 in flagellin detection. Our results provide genetic evidence that specific NAIP proteins function to detect specific bacterial proteins in vivo.


Subject(s)
Bacteria/immunology , Neuronal Apoptosis-Inhibitory Protein/immunology , Type III Secretion Systems/immunology , Animals , Bacteria/genetics , Flagellin/genetics , Flagellin/immunology , Mice , Mice, Knockout , Neuronal Apoptosis-Inhibitory Protein/genetics , Type III Secretion Systems/genetics
2.
Biochem Biophys Res Commun ; 461(4): 630-5, 2015 Jun 12.
Article in English | MEDLINE | ID: mdl-25918019

ABSTRACT

Preadipocyte factor-1 (Pref-1) is made as a transmembrane protein containing EGF-repeats at the extracellular domain that can be cleaved to generate a biologically active soluble form. Pref-1 is found in islet ß-cells and its level has been reported to increase in neonatal rat islets upon growth hormone treatment. We found here that Pref-1 can promote growth of pancreatic tumor derived AR42J cells. To examine Pref-1 function in pancreatic islets in vivo, we generated transgenic mouse lines overexpressing the Pref-1/hFc in islet ß-cells using rat insulin II promoter (RIP). These transgenic mice exhibit an increase in islet mass with higher proportion of larger islets in pancreas compared to wild-type littermates. This is in contrast to pancreas from Pref-1 null mice that show higher proportion of smaller islets. Insulin expression and insulin secretion from pancreatic islets from RIP-Pref-1/hFc transgenic mice are increased also. Thus, RIP-Pref-1/hFc transgenic mice show normal glucose levels but with higher plasma insulin levels in both fasting and fed conditions. These mice show improved glucose tolerance. Taken together, we conclude Pref-1 as a positive regulator of islet ß-cells and insulin production.


Subject(s)
Cell Proliferation , Hyperinsulinism/metabolism , Hyperinsulinism/pathology , Insulin-Secreting Cells/metabolism , Insulin-Secreting Cells/pathology , Insulin/metabolism , Intercellular Signaling Peptides and Proteins/metabolism , Animals , Calcium-Binding Proteins , Female , Insulin Resistance , Insulin Secretion , Mice , Mice, Inbred C57BL , Mice, Transgenic , Up-Regulation
3.
Mol Cell ; 57(2): 235-46, 2015 Jan 22.
Article in English | MEDLINE | ID: mdl-25578880

ABSTRACT

Uncoupling protein 1 (UCP1) mediates nonshivering thermogenesis and, upon cold exposure, is induced in brown adipose tissue (BAT) and subcutaneous white adipose tissue (iWAT). Here, by high-throughput screening using the UCP1 promoter, we identify Zfp516 as a transcriptional activator of UCP1 as well as PGC1α, thereby promoting a BAT program. Zfp516 itself is induced by cold and sympathetic stimulation through the cAMP-CREB/ATF2 pathway. Zfp516 directly binds to the proximal region of the UCP1 promoter, not to the enhancer region where other transcription factors bind, and interacts with PRDM16 to activate the UCP1 promoter. Although ablation of Zfp516 causes embryonic lethality, knockout embryos still show drastically reduced BAT mass. Overexpression of Zfp516 in adipose tissue promotes browning of iWAT even at room temperature, increasing body temperature and energy expenditure and preventing diet-induced obesity. Zfp516 may represent a future target for obesity therapeutics.


Subject(s)
Adipose Tissue, Brown/physiology , Adipose Tissue, White/physiology , Ion Channels/genetics , Mitochondrial Proteins/genetics , Trans-Activators/physiology , Adipogenesis , Adipose Tissue, Brown/cytology , Adipose Tissue, White/cytology , Animals , Cold-Shock Response , DNA-Binding Proteins/metabolism , HEK293 Cells , Humans , Ion Channels/metabolism , Mice, Inbred C57BL , Mice, Transgenic , Mitochondrial Proteins/metabolism , Muscle Development , Phenotype , Promoter Regions, Genetic , Protein Binding , Thermogenesis , Transcription Factors/metabolism , Transcription, Genetic , Transcriptional Activation , Uncoupling Protein 1
4.
Cell Rep ; 8(3): 678-87, 2014 Aug 07.
Article in English | MEDLINE | ID: mdl-25088414

ABSTRACT

Pref-1 is an EGF-repeat-containing protein that inhibits adipocyte differentiation. To better understand the origin and development of white adipose tissue (WAT), we generated transgenic mouse models for transient or permanent fluorescent labeling of cells using the Pref-1 promoter, facilitating inducible ablation. We show that Pref-1-marked cells retain proliferative capacity and are very early adipose precursors, prior to expression of Zfp423 or PPARγ. In addition, the Pref-1-marked cells establish that adipose precursors are mesenchymal, but not endothelial or pericytal, in origin. During embryogenesis, Pref-1-marked cells first appear in the dorsal mesenteric region as early as embryonic day 10.5 (E10.5). These cells become lipid-laden adipocytes at E17.5 in the subcutaneous region, whereas visceral WAT develops after birth. Finally, ablation of Pref-1-marked cells prevents not only embryonic WAT development but also later adult adipose expansion upon high-fat feeding, demonstrating the requirement of Pref-1 cells for adipogenesis.


Subject(s)
Adipogenesis , Adipose Tissue, White/metabolism , Intercellular Signaling Peptides and Proteins/metabolism , Mesoderm/cytology , Adipocytes, White/cytology , Adipocytes, White/metabolism , Adipose Tissue, White/cytology , Adipose Tissue, White/embryology , Animals , Calcium-Binding Proteins , Cells, Cultured , DNA-Binding Proteins/genetics , DNA-Binding Proteins/metabolism , Embryonic Stem Cells/cytology , Embryonic Stem Cells/metabolism , Intercellular Signaling Peptides and Proteins/genetics , Mesoderm/embryology , Mesoderm/metabolism , Mice , PPAR gamma/genetics , PPAR gamma/metabolism , Transcription Factors/genetics , Transcription Factors/metabolism
5.
Blood ; 123(26): 4089-100, 2014 Jun 26.
Article in English | MEDLINE | ID: mdl-24735967

ABSTRACT

Cancer develops by a multistep process during which cells acquire characteristics that allow them to evade apoptosis and proliferate unchecked. Sequential acquisition of genetic alterations drives this process but also causes cellular stress, frequently prompting cells to enter a premalignant period during which they mount a defense against transformation. T cell-specific deletion of the tumor suppressor PTEN in mice induces premalignancy in the thymus and development of CD4(+) T-cell lymphomas in the periphery. Here we sought to identify factors mediating the cellular defense against transformation during the premalignant period. We identified several microRNAs upregulated specifically in premalignant thymocytes, including miR-146a, miR-146b, and the miR-183/96/182 cluster. CD4-driven T cell-specific transgenic overexpression of mir-146a and mir-146b significantly delayed PTEN-deficient lymphomagenesis and delayed c-myc oncogene induction, a key driver of transformation in PTEN-deficient T-cell malignancies. We found that miR-146a and miR-146b targeting of Traf6 attenuates TCR signaling in the thymus and inhibits downstream NF-κB-dependent induction of c-myc. Additionally, c-myc repression in mature CD4 T cells by miR-146b impaired TCR-mediated proliferation. Hence, we have identified 2 miRNAs that are upregulated as part of the cellular response against transformation that, when overrepresented, can effectively inhibit progression to malignancy in the context of PTEN deficiency.


Subject(s)
Cell Transformation, Neoplastic/immunology , Lymphoma, T-Cell/immunology , MicroRNAs/immunology , PTEN Phosphohydrolase/immunology , RNA, Neoplasm/immunology , Thymocytes/immunology , Animals , CD4-Positive T-Lymphocytes/immunology , CD4-Positive T-Lymphocytes/metabolism , CD4-Positive T-Lymphocytes/pathology , Cell Proliferation , Cell Transformation, Neoplastic/genetics , Cell Transformation, Neoplastic/metabolism , Cell Transformation, Neoplastic/pathology , Gene Expression Regulation, Neoplastic/genetics , Gene Expression Regulation, Neoplastic/immunology , Lymphoma, T-Cell/genetics , Lymphoma, T-Cell/metabolism , Lymphoma, T-Cell/pathology , Mice , Mice, Knockout , MicroRNAs/biosynthesis , MicroRNAs/genetics , Multigene Family/genetics , Multigene Family/immunology , PTEN Phosphohydrolase/genetics , PTEN Phosphohydrolase/metabolism , Proto-Oncogene Proteins c-myc/biosynthesis , Proto-Oncogene Proteins c-myc/genetics , Proto-Oncogene Proteins c-myc/immunology , RNA, Neoplasm/biosynthesis , RNA, Neoplasm/genetics , Receptors, Antigen, T-Cell/genetics , Receptors, Antigen, T-Cell/immunology , Receptors, Antigen, T-Cell/metabolism , Signal Transduction/genetics , Signal Transduction/immunology , TNF Receptor-Associated Factor 6/genetics , TNF Receptor-Associated Factor 6/immunology , TNF Receptor-Associated Factor 6/metabolism , Thymocytes/metabolism , Thymocytes/pathology
6.
Science ; 339(6124): 1219-24, 2013 Mar 08.
Article in English | MEDLINE | ID: mdl-23471412

ABSTRACT

Despite considerable interest in the modulation of tumor-associated Foxp3(+) regulatory T cells (T(regs)) for therapeutic benefit, little is known about the developmental origins of these cells and the nature of the antigens that they recognize. We identified an endogenous population of antigen-specific T(regs) (termed MJ23 T(regs)) found recurrently enriched in the tumors of mice with oncogene-driven prostate cancer. MJ23 T(regs) were not reactive to a tumor-specific antigen but instead recognized a prostate-associated antigen that was present in tumor-free mice. MJ23 T(regs) underwent autoimmune regulator (Aire)-dependent thymic development in both male and female mice. Thus, Aire-mediated expression of peripheral tissue antigens drives the thymic development of a subset of organ-specific T(regs), which are likely coopted by tumors developing within the associated organ.


Subject(s)
Immune Tolerance , Prostate/immunology , Prostatic Neoplasms/immunology , T-Lymphocytes, Regulatory/immunology , Thymus Gland/growth & development , Thymus Gland/immunology , Transcription Factors/immunology , Animals , Antigens, Polyomavirus Transforming/genetics , Autoantigens/immunology , CD4 Antigens/analysis , Female , Forkhead Transcription Factors/analysis , Homeodomain Proteins/genetics , Male , Mice , Mice, Transgenic , Prostate-Specific Antigen/immunology , Transcription Factors/genetics , AIRE Protein
7.
Cell Metab ; 13(6): 739-48, 2011 Jun 08.
Article in English | MEDLINE | ID: mdl-21641555

ABSTRACT

While fatty acids (FAs) released by white adipose tissue (WAT) provide energy for other organs, lipolysis is also critical in brown adipose tissue (BAT), generating FAs for oxidation and UCP-1 activation for thermogenesis. Here we show that adipose-specific ablation of desnutrin/ATGL in mice converts BAT to a WAT-like tissue. These mice exhibit severely impaired thermogenesis with increased expression of WAT-enriched genes but decreased BAT genes, including UCP-1 with lower PPARα binding to its promoter, revealing the requirement of desnutrin-catalyzed lipolysis for maintaining a BAT phenotype. We also show that desnutrin is phosphorylated by AMPK at S406, increasing TAG hydrolase activity, and provide evidence for increased lipolysis by AMPK phosphorylation of desnutrin in adipocytes and in vivo. Despite adiposity and impaired BAT function, desnutrin-ASKO mice have improved hepatic insulin sensitivity with lower DAG levels. Overall, desnutrin is phosphorylated/activated by AMPK to increase lipolysis and brings FA oxidation and UCP-1 induction for thermogenesis.


Subject(s)
Adenylate Kinase/metabolism , Lipase/genetics , Protein Processing, Post-Translational , Adipose Tissue, Brown/metabolism , Adipose Tissue, White/metabolism , Adiposity/genetics , Animals , Cells, Cultured , Enzyme Assays , Gene Knockout Techniques , Ion Channels/genetics , Ion Channels/metabolism , Lipase/metabolism , Lipolysis/genetics , Male , Mice , Mice, Obese , Mitochondrial Proteins/genetics , Mitochondrial Proteins/metabolism , Phosphorylation , Thermogenesis , Uncoupling Protein 1
8.
J Biol Chem ; 285(10): 7556-65, 2010 Mar 05.
Article in English | MEDLINE | ID: mdl-20068041

ABSTRACT

Proliferation and apoptosis are diametrically opposite processes. Expression of certain genes like c-Myc, however, can induce both, pointing to a possible linkage between them. Developing CD4(+)CD8(+) thymocytes are intrinsically sensitive to apoptosis, but the molecular basis is not known. We have found that these noncycling cells surprisingly express many cell cycle proteins. We generated transgenic mice expressing a CDK2 kinase-dead (CDK2-DN) protein in the T cell compartment. Analysis of these mice showed that the CDK2-DN protein acts as a dominant negative mutant in mature T cells as expected, but surprisingly, it acts as a dominant active protein in CD4(+)CD8(+) thymocytes. The levels of CDK2 kinase activity, cyclin E, cyclin A, and other cell cycle proteins in transgenic CD4(+)CD8(+) thymocytes are increased. Concurrently, caspase levels are elevated, and apoptosis is significantly enhanced in vitro and in vivo. E2F-1, the unique E2F member capable of inducing apoptosis when overexpressed, is specifically up-regulated in transgenic CD4(+)CD8(+) thymocytes but not in other T cell populations. These results demonstrate that the cell cycle and apoptotic machineries are normally linked, and expression of cell cycle proteins in developing T cells contributes to their inherent 1sensitivity to apoptosis.


Subject(s)
Apoptosis/physiology , Cell Cycle/physiology , Cyclin-Dependent Kinase 2 , T-Lymphocytes/physiology , Animals , Cell Cycle Proteins/genetics , Cell Cycle Proteins/metabolism , Cell Proliferation , Cyclin-Dependent Kinase 2/genetics , Cyclin-Dependent Kinase 2/metabolism , DNA Fragmentation , Flow Cytometry , Humans , In Situ Nick-End Labeling , Mice , Mice, Transgenic , T-Lymphocytes/cytology , Thymus Gland/cytology
9.
Diabetes ; 58(4): 855-66, 2009 Apr.
Article in English | MEDLINE | ID: mdl-19136649

ABSTRACT

OBJECTIVE: To investigate the role of desnutrin in adipose tissue triacylglycerol (TAG) and fatty acid metabolism. RESEARCH DESIGN AND METHODS: We generated transgenic mice overexpressing desnutrin (also called adipose triglyceride lipase [ATGL]) in adipocytes (aP2-desnutrin) and also performed adenoviral-mediated overexpression of desnutrin in 3T3-L1CARDelta1 adipocytes. RESULTS: aP2-desnutrin mice were leaner with decreased adipose tissue TAG content and smaller adipocyte size. Overexpression of desnutrin increased lipolysis but did not result in increased serum nonesterified fatty acid levels or ectopic TAG storage. We found increased cycling between diacylglycerol (DAG) and TAG and increased fatty acid oxidation in adipocytes from these mice, as well as improved insulin sensitivity. CONCLUSIONS: We show that by increasing lipolysis, desnutrin overexpression causes reduced adipocyte TAG content and attenuation of diet-induced obesity. Desnutrin-mediated lipolysis promotes fatty acid oxidation and re-esterification within adipocytes.


Subject(s)
Adipose Tissue/physiology , Adipose Tissue/physiopathology , Carboxylic Ester Hydrolases/genetics , Energy Intake , Obesity/prevention & control , 3T3 Cells , Adipocytes/cytology , Adipocytes/physiology , Animals , Carboxylic Ester Hydrolases/physiology , Cloning, Molecular , Female , Lipase/metabolism , Lipolysis , Male , Mice , Mice, Inbred C57BL , Mice, Inbred CBA , Mice, Transgenic , Obesity/etiology , Promoter Regions, Genetic , RNA/genetics , Reverse Transcriptase Polymerase Chain Reaction , Triolein/metabolism
10.
Nat Med ; 15(2): 159-68, 2009 Feb.
Article in English | MEDLINE | ID: mdl-19136964

ABSTRACT

A main function of white adipose tissue is to release fatty acids from stored triacylglycerol for other tissues to use as an energy source. Whereas endocrine regulation of lipolysis has been extensively studied, autocrine and paracrine regulation is not well understood. Here we describe the role of the newly identified major adipocyte phospholipase A(2), AdPLA (encoded by Pla2g16, also called HREV107), in the regulation of lipolysis and adiposity. AdPLA-null mice have a markedly higher rate of lipolysis owing to increased cyclic AMP levels arising from the marked reduction in the amount of adipose prostaglandin E(2) that binds the Galpha(i)-coupled receptor, EP3. AdPLA-null mice have markedly reduced adipose tissue mass and triglyceride content but normal adipogenesis. They also have higher energy expenditure with increased fatty acid oxidation within adipocytes. AdPLA-deficient ob/ob mice remain hyperphagic but lean, with increased energy expenditure, yet have ectopic triglyceride storage and insulin resistance. AdPLA is a major regulator of adipocyte lipolysis and is crucial for the development of obesity.


Subject(s)
Adipocytes/enzymology , Dietary Fats/administration & dosage , Leptin/deficiency , Lipolysis , Obesity/prevention & control , Phospholipases A2/metabolism , Adipocytes/metabolism , Animals , Dinoprostone/metabolism , Energy Metabolism , Insulin Resistance , Mice , Mice, Knockout , Phospholipases A2/genetics
11.
Eur J Immunol ; 38(11): 3200-7, 2008 Nov.
Article in English | MEDLINE | ID: mdl-18991293

ABSTRACT

The PI3K-AKT pathway can mediate diverse biological responses and is crucial for optimal immune responses and lymphocyte development. Deletion of PI3K subunits or AKT leads to blockage of T-cell development at the TCR-beta checkpoint. Studies with over-expression of constitutively activated AKT have implicated this pathway in anti-apoptosis of developing thymocytes and in development of regulatory T cells. However, the role of endogenous PI3K-AKT in T-cell development beyond the TCR-beta checkpoint remains unclear. Here, we inhibited the endogenous PI3K-AKT pathway in thymocytes after double negative stages by expressing the negative regulator, PTEN. These mice exhibit normal early T-cell development, but the transition from intermediate single positive to double positive (DP) thymocytes is inhibited, leading to a significantly decreased number of DP, single positive thymocytes and peripheral T cells. Proliferation of peripheral T cells is reduced but apoptosis of DP cells and subsequent T-cell maturation, including regulatory T cells, are normal. AKT phosphorylation can be readily observed in most WT T-cell compartments but not DP thymocytes in response to TCR activation. Thus, the PI3K-AKT pathway is crucial for the transition of intermediate single positive to DP thymocytes but is dispensable for apoptosis and maturation of developing thymocytes.


Subject(s)
Phosphatidylinositol 3-Kinases/physiology , Proto-Oncogene Proteins c-akt/physiology , Signal Transduction/physiology , T-Lymphocytes/physiology , Animals , Apoptosis , Mice , Mice, Transgenic , PTEN Phosphohydrolase/physiology , Receptors, Antigen, T-Cell/physiology
12.
J Exp Med ; 205(4): 929-38, 2008 Apr 14.
Article in English | MEDLINE | ID: mdl-18378791

ABSTRACT

The production of distinct sets of T cell receptor (TCR) gammadelta(+) T cells occurs in an ordered fashion in thymic development. The Vgamma3 and Vgamma4 genes, located downstream in the TCRgamma Cgamma1 gene cluster, are expressed by the earliest waves of developing TCRgammadelta(+) T cells in the fetal thymus, destined for intraepithelial locations. Upstream Vgamma2 and Vgamma5 genes are expressed in later waves in the adult and constitute most TCRgammadelta(+) T cells in secondary lymphoid tissue. This developmental pattern is caused in part by a preference for rearrangements of the downstream Vgamma3 and Vgamma4 genes in the early fetal stage, which switches to a preference for rearrangements of the upstream Vgamma2 and Vgamma5 gene rearrangements in the adult. Our gene targeting studies show that the downstream Vgamma genes rearrange preferentially in the early fetal thymus because of their downstream location, independent of promoter or recombination signal sequences and unrelated to the extent of germline transcription. Remarkably, gene deletion studies show that the downstream Vgamma genes competitively inhibit upstream Vgamma rearrangements at the fetal stage. These data provide a mechanism for specialization of the fetal thymus for the production of T cells expressing specific Vgamma genes.


Subject(s)
Gene Rearrangement, gamma-Chain T-Cell Antigen Receptor/genetics , Animals , DNA Restriction Enzymes/metabolism , Fetus/immunology , Gene Deletion , Gene Targeting , Germ Cells , Mice , Thymus Gland/cytology , Thymus Gland/immunology , Transcription, Genetic
13.
Science ; 319(5860): 215-20, 2008 Jan 11.
Article in English | MEDLINE | ID: mdl-18187659

ABSTRACT

Substantial evidence exists that many tumors can be specifically recognized by CD8+ T lymphocytes. The definition of antigens targeted by these cells is paramount for the development of effective immunotherapeutic strategies for treating human cancers. In a screen for endogenous tumor-associated T cell responses in a primary mouse model of prostatic adenocarcinoma, we identified a naturally arising CD8+ T cell response that is reactive to a peptide derived from histone H4. Despite the ubiquitous nature of histones, T cell recognition of histone H4 peptide was specifically associated with the presence of prostate cancer in these mice. Thus, the repertoire of antigens recognized by tumor-infiltrating T cells is broader than previously thought and includes peptides derived from ubiquitous self antigens that are normally sequestered from immune detection.


Subject(s)
Adenocarcinoma/immunology , Antigens, Neoplasm/immunology , Autoantigens/immunology , CD8-Positive T-Lymphocytes/immunology , Histones/immunology , Lymphocytes, Tumor-Infiltrating/immunology , Prostatic Neoplasms/immunology , Adoptive Transfer , Animals , Antigen Presentation , Cell Line , Epitopes, T-Lymphocyte/immunology , Hybridomas , Male , Mice , Mice, Transgenic , Peptide Fragments/immunology , Receptors, Antigen, T-Cell, alpha-beta/immunology
14.
J Immunol ; 174(11): 6732-41, 2005 Jun 01.
Article in English | MEDLINE | ID: mdl-15905513

ABSTRACT

Although Notch plays a crucial role in T cell development, regulation of Notch signaling in the thymus is not well understood. Kuzbanian, an ADAM protease, has been implicated in the cleavage of both Notch receptors and the Notch ligand, Delta. In this study we show that the expression of a dominant-negative form of Kuzbanian (dnKuz) leads to reduced TCRbeta expression in double-negative thymocytes and to a partial block between the double-negative to double-positive stages of development. These defects were rescued by overexpression of Delta-1 on thymocytes. Mixed chimeras showed a cell-autonomous block by dnKuz, but non-cell-autonomous rescue by Delta-1. This suggests that dnKuz impairs Notch signaling in receiving cells, and increasing Delta-1 on sending cells overcomes this defect. Interestingly, the expression of an activated form of Notch-1 rescued some, but not all, the defects in dnKuz Tg mice. Our data suggest that multiple Notch-dependent steps in early thymocyte development require Kuzbanian, but differ in the involvement of other Notch signaling components.


Subject(s)
Cell Differentiation/immunology , Membrane Proteins/genetics , Membrane Proteins/physiology , Metalloendopeptidases/genetics , Receptors, Cell Surface/metabolism , T-Lymphocytes/metabolism , Thymus Gland/metabolism , Transcription Factors/metabolism , ADAM Proteins , ADAM10 Protein , Amyloid Precursor Protein Secretases , Animals , Cell Differentiation/genetics , Gene Expression Regulation/immunology , Growth Inhibitors/genetics , Growth Inhibitors/physiology , Humans , Intracellular Signaling Peptides and Proteins , Ligands , Membrane Proteins/biosynthesis , Membrane Proteins/metabolism , Metalloendopeptidases/metabolism , Metalloendopeptidases/physiology , Mice , Mice, Inbred C57BL , Mice, Inbred CBA , Mice, Transgenic , Radiation Chimera , Receptor, Notch1 , Receptors, Antigen, T-Cell, alpha-beta/antagonists & inhibitors , Receptors, Antigen, T-Cell, alpha-beta/biosynthesis , Receptors, Antigen, T-Cell, alpha-beta/genetics , Receptors, Cell Surface/biosynthesis , Receptors, Cell Surface/genetics , Receptors, Cell Surface/physiology , Signal Transduction/genetics , Signal Transduction/immunology , T-Lymphocytes/enzymology , T-Lymphocytes/pathology , Thymus Gland/enzymology , Thymus Gland/pathology , Transcription Factors/biosynthesis , Transcription Factors/genetics , Transcription Factors/physiology
15.
Genes Dev ; 18(24): 3106-16, 2004 Dec 15.
Article in English | MEDLINE | ID: mdl-15601824

ABSTRACT

BAF and PBAF are two related mammalian chromatin remodeling complexes essential for gene expression and development. PBAF, but not BAF, is able to potentiate transcriptional activation in vitro mediated by nuclear receptors, such as RXRalpha, VDR, and PPARgamma. Here we show that the ablation of PBAF-specific subunit BAF180 in mouse embryos results in severe hypoplastic ventricle development and trophoblast placental defects, similar to those found in mice lacking RXRalpha and PPARgamma. Embryonic aggregation analyses reveal that in contrast to PPARgamma-deficient mice, the heart defects are likely a direct result of BAF180 ablation, rather than an indirect consequence of trophoblast placental defects. We identified potential target genes for BAF180 in heart development, such as S100A13 as well as retinoic acid (RA)-induced targets RARbeta2 and CRABPII. Importantly, BAF180 is recruited to the promoter of these target genes and BAF180 deficiency affects the RA response for CRABPII and RARbeta2. These studies reveal unique functions of PBAF in cardiac chamber maturation.


Subject(s)
Chromatin Assembly and Disassembly/genetics , Gene Expression Regulation, Developmental , Heart Defects, Congenital/genetics , Nuclear Proteins/deficiency , Transcription Factors/deficiency , Animals , Cell Aggregation/genetics , DNA Primers , DNA-Binding Proteins , HMGB Proteins , Heart Defects, Congenital/metabolism , Immunoprecipitation/methods , In Situ Hybridization , In Situ Nick-End Labeling , Mice , Mice, Knockout , Nuclear Proteins/metabolism , Oligonucleotide Array Sequence Analysis , Placenta/abnormalities , Receptors, Retinoic Acid/metabolism , Reverse Transcriptase Polymerase Chain Reaction , S100 Proteins/metabolism , Transcription Factors/metabolism
16.
Proc Natl Acad Sci U S A ; 101(17): 6780-5, 2004 Apr 27.
Article in English | MEDLINE | ID: mdl-15090646

ABSTRACT

Adipocyte-specific secretory factor (ADSF)/resistin is a small cysteine-rich protein secreted from adipose tissue that belongs to a gene family found in inflammatory zone (FIZZ) or found in resistin-like molecule (RELM). ADSF has been implicated in modulating adipogenesis and insulin resistance. To examine the long-term function of ADSF in adipogenesis and glucose homeostasis, we constructed an expression vector for a dominant inhibitory form of ADSF by fusing it to the human IgGgamma constant region (hFc). ADSF-hFc not only homodimerizes but heterooligomerizes with ADSF/resistin and prevents ADSF/resistin inhibition of adipocyte differentiation of 3T3-L1 cells in a dominant negative manner. Transgenic mice overexpressing ADSF-hFc in adipose tissue show increased adiposity with elevated expression of adipocyte markers as well as enlarged adipocyte size. This finding clearly demonstrates in vivo the inhibitory role of ADSF in adipogenesis. ADSF-hFc transgenic mice with impaired ADSF function exhibit improved glucose tolerance and insulin sensitivity either on chow or high-fat diets. Because of the enhanced adipocyte differentiation, the ADSF-hFc transgenic mice show increased expression of leptin and adiponectin in adipose tissue. The elevated circulating levels for these adipocyte-derived hormones with decreased plasma triglyceride and free fatty acid levels may account for the improved glucose and insulin tolerance in these transgenic mice.


Subject(s)
Adipocytes/cytology , Cell Division/physiology , Hormones, Ectopic/physiology , 3T3-L1 Cells , Animals , Blotting, Northern , Blotting, Western , Cell Differentiation/physiology , Glucose Tolerance Test , Insulin Resistance , Mice , Mice, Transgenic , Resistin , Reverse Transcriptase Polymerase Chain Reaction
17.
J Exp Med ; 199(6): 825-30, 2004 Mar 15.
Article in English | MEDLINE | ID: mdl-15007090

ABSTRACT

Mice deficient for the B cell-restricted transcription factor Pax5 show a defect in the VH to DJH rearrangement step of immunoglobulin heavy chain gene assembly even though the expression of the V(D)J recombinase is not diminished in Pax5-/- pro-B cells. To investigate whether Pax5 is limiting for VH to DJH rearrangement, we generated transgenic mice which express Pax5 in developing thymocytes. We show that enforced expression of Pax5 in thymocytes results in a partial block in T cell development due to defective pre-TCR signaling in beta-selection. Moreover, our results demonstrate that expression of Pax5 in early thymocytes is sufficient to induce VH to DJH rearrangements in CD4+CD8+ T cells and lead us to suggest that Pax5 may play a direct role in the lineage-specific regulation of immunoglobulin heavy chain gene rearrangement.


Subject(s)
DNA-Binding Proteins/metabolism , Gene Expression , Gene Rearrangement, B-Lymphocyte/physiology , Genes, Immunoglobulin/physiology , Transcription Factors/metabolism , Animals , DNA-Binding Proteins/genetics , DNA-Binding Proteins/physiology , Flow Cytometry , Mice , Mice, Transgenic , PAX5 Transcription Factor , Polymerase Chain Reaction/methods , Receptors, Antigen, T-Cell/metabolism , Selectins/metabolism , Signal Transduction/physiology , T-Lymphocytes/physiology , Thymus Gland/cytology , Thymus Gland/physiology , Transcription Factors/genetics , Transcription Factors/physiology , VDJ Recombinases/metabolism
18.
Proc Natl Acad Sci U S A ; 101(1): 260-5, 2004 Jan 06.
Article in English | MEDLINE | ID: mdl-14691262

ABSTRACT

Developmentally regulated V(D)J recombination profoundly influences immune repertoires, but the underlying mechanisms are poorly understood. In the endogenous T cell receptor Cgamma1 cluster, the 3' Vgamma3 gene (closest to Jgamma1) rearranges preferentially in the fetal period whereas rearrangement of the 5' Vgamma2 gene predominates in the adult. Reversing the positions of the Vgamma2 and Vgamma3 genes in a genomic transgene resulted in decreased rearrangement of the now 5' Vgamma3 gene in the fetal thymus and increased rearrangement of the now 3' Vgamma2 gene. The reversed rearrangement pattern was not accompanied by significant changes in chromatin accessibility of the relocated Vgamma genes. The results support a model in which the 3' location is the key determinant of rearrangement in the fetus, after which there is a promoter-dependent inactivation of Vgamma3 rearrangement in favor of Vgamma2 rearrangement.


Subject(s)
Gene Rearrangement, gamma-Chain T-Cell Antigen Receptor , Animals , Dendritic Cells/immunology , Fetus/immunology , Gene Expression Regulation, Developmental , Mice , Mice, Inbred C57BL , Mice, Inbred CBA , Mice, Transgenic , Models, Genetic , Models, Immunological , Promoter Regions, Genetic , T-Lymphocytes/immunology
19.
J Exp Med ; 199(1): 69-80, 2004 Jan 05.
Article in English | MEDLINE | ID: mdl-14699085

ABSTRACT

Survivin is an inhibitor of apoptosis protein that also functions during mitosis. It is expressed in all common tumors and tissues with proliferating cells, including thymus. To examine its role in apoptosis and proliferation, we generated two T cell-specific survivin-deficient mouse lines with deletion occurring at different developmental stages. Analysis of early deleting survivin mice showed arrest at the pre-T cell receptor proliferating checkpoint. Loss of survivin at a later stage resulted in normal thymic development, but peripheral T cells were immature and significantly reduced in number. In contrast to in vitro studies, loss of survivin does not lead to increased apoptosis. However, newborn thymocyte homeostatic and mitogen-induced proliferation of survivin-deficient T cells were greatly impaired. These data suggest that survivin is not essential for T cell apoptosis but is crucial for T cell maturation and proliferation, and survivin-mediated homeostatic expansion is an important physiological process of T cell development.


Subject(s)
Apoptosis/immunology , Microtubule-Associated Proteins/genetics , T-Lymphocytes/immunology , Animals , Genotype , Homeostasis , Inhibitor of Apoptosis Proteins , Lymphocyte Activation/immunology , Mice , Microtubule-Associated Proteins/physiology , Neoplasm Proteins , Restriction Mapping , Survivin
20.
EMBO J ; 22(24): 6526-36, 2003 Dec 15.
Article in English | MEDLINE | ID: mdl-14657025

ABSTRACT

Nur77 is a nuclear orphan steroid receptor that has been implicated in negative selection. Expression of Nur77 in thymocytes and cell lines leads to apoptosis through a mechanism that remains unclear. In some cell lines, Nur77 was reported to act through a transcription-independent mechanism involving translocation to mitochondria, leading to cytochrome c release. However, we show here that Nur77-mediated apoptosis in thymocytes does not involve cytoplasmic cytochrome c release and cannot be rescued by Bcl-2. Microarray analysis shows that Nur77 induces many genes, including two novel genes (NDG1, NDG2) and known apoptotic genes FasL and TRAIL. Characterization of NDG1 and NDG2 indicates that NDG1 initiates a novel apoptotic pathway in a Bcl-2-independent manner. Thus Nur77-mediated apoptosis in T cells involves Bcl-2 independent transcriptional activation of several known and novel apoptotic pathways.


Subject(s)
Apoptosis/physiology , DNA-Binding Proteins/physiology , Receptors, Steroid/physiology , T-Lymphocytes/physiology , Transcription Factors/physiology , Transcriptional Activation/genetics , Amino Acid Sequence , Animals , Base Sequence , Cells, Cultured , Cloning, Molecular , DNA Primers , DNA-Binding Proteins/genetics , Escherichia coli/cytology , Escherichia coli/genetics , Escherichia coli/physiology , Female , Genotype , Humans , Mice , Mice, Inbred C57BL , Mice, Transgenic , Molecular Sequence Data , Nuclear Receptor Subfamily 4, Group A, Member 1 , Oligonucleotide Array Sequence Analysis , Pregnancy , Rats , Receptors, Antigen, T-Cell/physiology , Receptors, Cytoplasmic and Nuclear , Reverse Transcriptase Polymerase Chain Reaction , T-Lymphocytes/cytology , T-Lymphocytes/immunology , Transcription Factors/genetics
SELECTION OF CITATIONS
SEARCH DETAIL